Klonos Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -75.98%
- Profit Growth 56.47%
- Ebitda -14.70%
- Net Worth -27.39%
- Total Assets 20.83%
About Klonos Life Sciences
Klonos Life Sciences Private Limited (KLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 14 September 2017 (Seven years and four months 18 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rishad Kalappurakkal and Bineesh Skaria serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U73200KL2017PTC050418
- Company No.
050418
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
What products or services does Klonos Life Sciences Private Limited offer?
Klonos Life Sciences Private Limited offers a wide range of products and services, including Testing & Measuring Equipments, Water Testing Kits, Material Testing Labs & Services, Testing Services, Diagnostic Imaging & Pathology Labs, Medical Test Services.
Who are the key members and board of directors at Klonos Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishad Kalappurakkal  | Director | 14-Sep-2017 | Current |
| Bineesh Skaria | Director | 14-Sep-2017 | Current |
Financial Performance of Klonos Life Sciences.
Klonos Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 75.98% decrease. The company also saw a substantial improvement in profitability, with a 56.47% increase in profit. The company's net worth observed a substantial decline by a decrease of 27.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Klonos Life Sciences?
Unlock access to Klonos Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Zygene Biotechnologies Private LimitedRishad Kalappurakkal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Klonos Life Sciences?
Unlock and access historical data on people associated with Klonos Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Klonos Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klonos Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.